Status:
UNKNOWN
Surgery Alone Versus Methotrexate Before Surgery in Cesarean Scar Pregnancy
Lead Sponsor:
Mansoura University
Conditions:
Cesarean Scar Pregnancy
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
There are no universal treatment guidelines available. The ultimate purpose of the management of CSP is to simultaneously remove the pregnancy and successfully preserve the woman's fertility (Gonzalez...
Detailed Description
This will be a randomized clinical trial to evaluate the effect of administration of methotrexate before surgery in reducing bleeding, injury to bladder and ureter, operative time and removing of CSP ...
Eligibility Criteria
Inclusion
- •
- Gestational age before 13 w
- Past history of 1 or more CS
- Presence of GS implanted on cesareans scar
Exclusion
- Presence of severe vaginal bleeding (emergency)
- Previous history of uterine surgery other than CS
- The whole mass is interior and the bulge is more in the cavity
- Bleeding disorder
- Patient not candidate for methotrexate (Positive fetal heart pulsation,
- Patient refuse to participate in the study
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04379219
Start Date
December 1 2019
End Date
December 1 2020
Last Update
May 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University
Al Mansurah, Dakahliya, Egypt